Search

John Kwon

Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )

Most Active Art Unit
3747
Art Unit(s)
2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622
Total Applications
4781
Issued Applications
4291
Pending Applications
92
Abandoned Applications
420

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18559760 [patent_doc_number] => 11724994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Acesulfame potassium compositions and processes for producing same [patent_app_type] => utility [patent_app_number] => 17/206230 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15924 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206230 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206230
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 20480314 [patent_doc_number] => 12528785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => MDM2 degraders and uses thereof [patent_app_type] => utility [patent_app_number] => 17/912416 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 159703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912416 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912416
MDM2 degraders and uses thereof Mar 18, 2021 Issued
Array ( [id] => 16977543 [patent_doc_number] => 20210221780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same [patent_app_type] => utility [patent_app_number] => 17/206265 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206265
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 18545255 [patent_doc_number] => 11718594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Acesulfame potassium compositions and processes for producing same [patent_app_type] => utility [patent_app_number] => 17/206191 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16050 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206191 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206191
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 18753897 [patent_doc_number] => 20230357222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON [patent_app_type] => utility [patent_app_number] => 17/911564 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911564
SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON Mar 15, 2021 Abandoned
Array ( [id] => 16977587 [patent_doc_number] => 20210221824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/203457 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203457 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/203457
HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE Mar 15, 2021 Abandoned
Array ( [id] => 17065721 [patent_doc_number] => 20210267936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => COMBINATION THERAPIES [patent_app_type] => utility [patent_app_number] => 17/202755 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202755
Combination therapies Mar 15, 2021 Issued
Array ( [id] => 17185168 [patent_doc_number] => 20210332053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => HETEROCYCLIC COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/201878 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201878
Heterocyclic compound and use thereof Mar 14, 2021 Issued
Array ( [id] => 16946614 [patent_doc_number] => 20210205305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/201750 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 120074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201750
Spirocyclic compounds as tryptophan hydroxylase inhibitors Mar 14, 2021 Issued
Array ( [id] => 17020858 [patent_doc_number] => 20210244729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION [patent_app_type] => utility [patent_app_number] => 17/201736 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201736
NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION Mar 14, 2021 Abandoned
Array ( [id] => 17314814 [patent_doc_number] => 20210403862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/195385 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195385 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/195385
Methods of enhancing cell survival of stem cells Mar 7, 2021 Issued
Array ( [id] => 18405747 [patent_doc_number] => 20230167098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => HETEROCYCLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 17/905538 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905538 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905538
Heterocyclic compound Mar 3, 2021 Issued
Array ( [id] => 18413097 [patent_doc_number] => 11667630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Nitrogen-containing 6-membered cyclic compound [patent_app_type] => utility [patent_app_number] => 17/192614 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40330 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/192614
Nitrogen-containing 6-membered cyclic compound Mar 3, 2021 Issued
Array ( [id] => 19808281 [patent_doc_number] => 12239640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target [patent_app_type] => utility [patent_app_number] => 17/430655 [patent_app_country] => US [patent_app_date] => 2021-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5407 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430655
Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target Feb 19, 2021 Issued
Array ( [id] => 17052140 [patent_doc_number] => 20210261574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => BORON-CONTAINING SMALL MOLECULES [patent_app_type] => utility [patent_app_number] => 17/174586 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174586 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/174586
BORON-CONTAINING SMALL MOLECULES Feb 11, 2021 Abandoned
Array ( [id] => 18267084 [patent_doc_number] => 20230088326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => PROCESS FOR PREPARATION OF ARTHROPODICIDAL ANTHRANILAMIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/798970 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6021 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798970 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/798970
PROCESS FOR PREPARATION OF ARTHROPODICIDAL ANTHRANILAMIDE COMPOUNDS Feb 10, 2021 Pending
Array ( [id] => 16970460 [patent_doc_number] => 11066421 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-07-20 [patent_title] => Synthetic cinchona alkaloids against cancer [patent_app_type] => utility [patent_app_number] => 17/171601 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17993 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171601 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/171601
Synthetic cinchona alkaloids against cancer Feb 8, 2021 Issued
Array ( [id] => 18362188 [patent_doc_number] => 20230143779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/904247 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904247 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/904247
ORGANIC SOLID-STATE LASER, COMPOUND AND USE THEREOF Feb 8, 2021 Pending
Array ( [id] => 17007003 [patent_doc_number] => 20210238164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/170396 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33416 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170396 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/170396
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Feb 7, 2021 Issued
Array ( [id] => 18279900 [patent_doc_number] => 20230095372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => MULTICYCLIC CARBOCATION AND CARBORADICAL COMPOUNDS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/793204 [patent_app_country] => US [patent_app_date] => 2021-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21590 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793204 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/793204
MULTICYCLIC CARBOCATION AND CARBORADICAL COMPOUNDS AND METHODS OF USE Jan 30, 2021 Pending
Menu